Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date PathAI PD-L1(28-8)integration on Roche navify Digital Pathology open environment Eric Walk, MD, Chief Medical Officer, PathAI In this webinar, Dr. Walk will discuss how PathAI aims to improve cancer patient outcomes using the power of Artificial Intelligence, the importance o... 2 weeks ago | 60 mins HER2 Testing: Towards a Brighter Future Dr. Sangeeta Desai, Dr. Suseela Kodandapani and Dr. Veena R This webinar, sponsored by Roche, provided valuable insights into the latest advances in HER2 diagnostics in breast cancer. Dr. Sangeeta Desai, Profes... 2 months ago | 76 mins Cost effectiveness analysis of PD-L1 testing in NSCLC - IVD vs LDT Jason Hurwitz, BA, MA, Phd; Shannon Vaffis, MPH, Phd; Amy Grizzle, BA, Pharm D This webinar will share compelling research that evaluated the cost-effectiveness of PD-L1 testing with an in vitro diagnostic (IVD) compared to a lab... 7 months ago | 45 mins Using the Lumin Platform to Build Prediction Models of Olaparib Sensitivity Day2 Clare Killick-Cole, PhD & Art Hanson, MSCS Day 2: Enriching your Multi-omic Dataset and Building Highly Predictive Models of Response Sensitivity Learn more about these topics by registering ... 1 year ago | 48 mins 固形がんにおけるDNAミスマッチ修復(MMR) 機能異常とその臨床的意義 〜IHC検査とがん免疫療法の臨床事例を踏まえて〜 Dr. Takeshi Kuwata and Dr. Akihito Kawazoe, both from National Cancer Center Hospital East, Chiba, Japan (Note: This webinar will be presented in Japanese.) In this webinar, our speakers will discuss mechanisms and clinical evaluation of DNA mismatch repa... 7 months ago | 62 mins NTRK gene fusions in solid tumors: IHC and molecular testing strategies Caterina Marchiò, MD, PhD and Reinhard Büttner, MD In this webinar Drs. Marchiò and Büttner will review the role of NTRK gene fusions in solid tumors, with an in-depth look at IHC and molecular methods... 2 years ago | 61 mins Lung Cancer Diagnostics: Evolving Practice and Future Directions Professor Keith Kerr Personalized medicine for non-small-cell lung cancer (NSCLC) continues to evolve rapidly, building on a solid diagnostic foundation based on H&E and i... 3 years ago | 61 mins Lung Cancer Biomarker Testing Dr. Paul A. Bunn Jr, MD Lung Cancer Biomarker Testing presented by Dr. Paul A. Bunn Jr, MD, Distinguished Professor and Dudley Endowed Chair University of Colorado Cancer Cen... 4 years ago | 20 mins Validation of Low Prevalence Biomarkers in the Laboratory Dr. Dylan Miller, University of Utah, Utah USA and Dr. Emina Torlakovic, University of Saskatchewan, Saskatoon, SK Canada In this BrightTALK webinar, Dr. Dylan Miller and Dr. Emina Torlakovic will discuss approaches and perspectives on validation of low prevalence biomark... 2 years ago | 76 mins NTRK Testing: Practical Considerations for IHC Interpretation Dr. Lawrence Weiss and Dr. Fernando López-Ríos As pan-TRK IHC evaluation becomes a more integrated part of NTRK testing in clinical practice, take the opportunity to learn from Dr. Lawrence Weiss (... 2 years ago | 120 mins Load more
